Rankings
▼
Calendar
NTRA Q1 2019 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena
NTRA
Natera, Inc.
$28B
Q1 2019 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$67M
+7.2% YoY
Gross Profit
$24M
35.2% margin
Operating Income
-$32M
-47.5% margin
Net Income
-$34M
-51.0% margin
EPS (Diluted)
$-0.54
QoQ Revenue Growth
-0.2%
Cash Flow
Operating Cash Flow
-$32M
Free Cash Flow
-$33M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$261M
Total Liabilities
$256M
Stockholders' Equity
$5M
Cash & Equivalents
$34M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$67M
$62M
+7.2%
Gross Profit
$24M
$22M
+8.2%
Operating Income
-$32M
-$31M
-4.0%
Net Income
-$34M
-$33M
-3.7%
Revenue Segments
Product
$63M
47%
Panorama Nipt
$37M
28%
Hcs
$23M
17%
Licensing And Other
$3M
3%
Other Genetic Tests
$3M
3%
Other Licensing And Other
$2M
1%
Constellation
$1M
1%
Qiagen
$148,000
0%
Geographic Segments
U
$60M
90%
E M E A
$4M
6%
Other Geographic Areas
$2M
3%
Americas Excluding Us
$818,000
1%
← FY 2019
All Quarters
Q2 2019 →